Fusion Finance (FUSION)

FairStock Score: 24/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at 1.17 times book value (book value ₹155.69 vs price ₹181.80), limiting downside if book remains intact.
• Promoter holding is high at 54.92%, aligning management with minority shareholders.
• Latest quarter turned net positive with ₹14 Cr profit on ₹416 Cr sales, suggesting possible stabilisation after losses.
• Piotroski F-Score of 5/9 is moderate, indicating some fundamental improvements amid distress.

Concerns

• Trailing P/E is 0.00 because earnings are negative; ROE of -10.50% and ROCE of -2.96% show capital is being destroyed.
• Sales growth is -12.11%, so the loan book/business is shrinking.
• Debt/equity of 2.58 is high; for a microfinance lender this magnifies credit and collection risks.
• Zero dividend offers no income protection while waiting for recovery.

AI Analysis

Let me look at Fusion Finance as a business, not a ticker. It is a microfinance lender, a commodity-like business where pricing power is limited and credit risk is central. The financials tell me this is a business under stress. Trailing earnings are negative, hence the P/E of 0.00, and returns are poor: ROE -10.50%, ROCE -2.96%. With debt/equity at 2.58, shareholders' equity bears a heavy burden. Book value is ₹155.69 and the stock trades at ₹181.80, about 1.17 times book. A premium to book is justified only if the company can earn above its cost of equity; at -10.5% ROE, it is destroying value, not compounding it. Sales fell 12.11%, so the top line is shrinking. Profit growth of 101.95% sounds dramatic but starts from a deeply negative base; the latest quarter's net profit of ₹14 Cr on ₹416 Cr sales is a thin ~3.4% margin. That is a hint of stabilization, not yet evidence of a durable turnaround. The promoter holding of 54.92% is positive alignment, and the Piotroski score of 5/9 is mediocre, not terrible. There is no dividend, so the retail investor must rely entirely on recovery and capital gains. In Graham's language, this is not a defensive stock; it is a speculative enterprise. I would demand a large margin of safety, but at 1.17 times book with weak returns, that margin is not obvious. I need to see sustained profitability, improving sales, and lower leverage before I can call it an investment. For now, it's a show-me story, not a compounder.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer